- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02895867
Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes
Effect of Consumption of Dairy Products on Glycemic Control, Body Weight and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Randomized Controlled Clinical Study
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a randomized, controlled clinical study in which 108 subjects with type 2 diabetes will be randomized into 3 different groups:
Full fat dairy group (Group A): will receive nutritional counseling aiming to maintain body weight from a registered dietician and will be instructed to include at least ≥3 servings of full fat dairy products into their diet
Low fat dairy group (Group B): will receive nutritional counseling aiming to maintain body weight from a registered dietician and will be instructed to include at least ≥3 servings of low fat dairy products into their diet
Control group (Group C): will receive nutritional counseling aiming to maintain body weight from a registered dietician and will not be asked to include a specified amount or type of dairy products
Subjects in Groups A and B will be educated about different dairy products' serving sizes and fat content. Subjects in all 3 groups will be asked to record their daily intake of dairy products in a dedicated log book. Subjects randomized to groups A and B will be asked to only use only dairy products with either the full fat or and low (≤1%) fat dairy (≤1% fat content) content respectively. Purchase of the dairy products will be the responsibility of study subjects for which a subsidy of $500 (about $20/week for 24 weeks) will be provided for each subject. All study participants will also be asked to record their food intake for 3 days before each study visit in a 3-day food log.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02215
- Joslin Diabetes Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Having type 2 diabetes for at least three months prior to screening and treated with any antihyperglycemic medication
- A1C ≥7 %
- Consuming <3 servings of dairy products per day
- On stable dose of diabetes, blood pressure or cholesterol medications for 3 months
- Body weight is within 10% of current weight over the last 6 months before starting the study
Exclusion Criteria:
- Pregnancy or lactation
- Lactose intolerance
- Allergy to milk or any of its components
- Use of orlistat
- History of pancreatitis
- History of gastric bypass surgery or sleeve gastrectomy
- Active malignancy
- History of recent cardiovascular event
- Having a heart pacemaker
- Enrollment in other studies that may affect study outcomes
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Full fat dairy group
Participants will receive nutritional counseling aiming to maintain body weight from a registered dietitian and will be instructed to include at least ≥3 servings of full fat dairy products into their diet
|
Participants will receive nutritional counseling aiming to maintain body weight from a registered dietician and will be instructed to include at least ≥3 servings of full fat dairy products into their diet
|
Experimentell: Low fat dairy group
Participants will receive nutritional counseling aiming to maintain body weight from a registered dietitian and will be instructed to include at least ≥3 servings of low fat dairy products into their diet
|
Participants will receive nutritional counseling aiming to maintain body weight from a registered dietician and will be instructed to include at least ≥3 servings of low fat dairy products into their diet
|
Övrig: Control group
Participants will receive nutritional counseling aiming to maintain body weight from a registered dietician and will not be asked to include a specified amount or type of dairy products
|
Participants will receive nutritional counseling aiming to maintain body weight from a registered dietician and will not be asked to include a specified amount or type of dairy products
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Change in Hemoglobin A1C (A1C)
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in body weight
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in total cholesterol
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in high-density lipoprotein (HDL)
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in low-density lipoprotein (LDL)
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in triglycerides
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in fasting plasma glucose
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in Homeostatic model assessment (HOMA) insulin resistance (IR) index after 24 weeks compared to baseline
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in body fat percentage
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in fat free mass
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Height in meters
Tidsram: Baseline
|
Used in calculation of Body Mass Index
|
Baseline
|
Change in total body water
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in waist circumference
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in trunk fat percentage
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in visceral fat level
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in blood pressure
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
|
Change in c-reactive protein level
Tidsram: Baseline, 12 weeks and 24 weeks
|
Baseline, 12 weeks and 24 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Osama Hamdy, M.D., Ph.D., Joslin Diabetes Center
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2016-04
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Diabetes typ 2
-
Bnai Zion Medical CenterOkänd
-
Jiangsu HengRui Medicine Co., Ltd.Avslutad
-
Mathias Ried-LarsenOkändDiabetes mellitus, typ 2 | Typ 2-diabetes mellitus | Diabetes typ 2 | Typ 2 diabetes mellitusDanmark
-
Shanghai HEP Pharmaceutical Co., Ltd.Indragen
-
Asahi Kasei Pharma CorporationRekryteringTyp 2-diabetes mellitusKina
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkAktiv, inte rekryterande
-
Regor Pharmaceuticals Inc.AvslutadTyp 2-diabetes mellitusFörenta staterna
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Avslutad
-
Endocrine Research SocietyAvslutadTyp 2-diabetes mellitusKanada
-
University Hospital TuebingenAktiv, inte rekryterande
Kliniska prövningar på Full fat dairy
-
Brock UniversityDairy Farmers of CanadaAvslutadFetma | Övervikt | BarnKanada
-
Medtronic Neurovascular Clinical AffairsAvslutadIntrakraniellt bifurkerande aneurysmFörenta staterna
-
USDA, Western Human Nutrition Research CenterIowa State UniversityAvslutad
-
University of ManitobaAvslutad
-
Midwest Heart & Vascular SpecialistsRekryteringAL Amyloidos | Amyloid | Hjärtamyloidos | Amyloidos Hjärtat | Systemisk amyloidos | ATTR Amyloidosis Vildtyp | Infiltrativ kardiomyopati, amyloidFörenta staterna
-
Klein Buendel, Inc.Pennington Biomedical Research CenterAvslutadSömnbrist | Övervikt och fetma | HälsobeteendeFörenta staterna
-
Hvidovre University HospitalUniversity of Copenhagen; Danish Research Centre for Magnetic ResonanceAvslutadDiabetes | Metaboliskt syndrom | NAFLD | Övervikt och fetmaDanmark
-
BravaAvslutadMastektomi | Mammaplastik | LumpektomiFörenta staterna
-
Riphah International UniversityRekryteringMuskeltäthetPakistan